BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 32773568)

  • 21. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.
    Biermann M; Kråkenes J; Brauckhoff K; Haugland HK; Heinecke A; Akslen LA; Varhaug JE; Brauckhoff M
    Acta Radiol; 2015 Nov; 56(11):1350-60. PubMed ID: 25770086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
    Raue F; Frank-Raue K
    Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal imaging of thyroid cancer.
    Brauckhoff K; Biermann M
    Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):335-344. PubMed ID: 32773568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
    Ciarallo A; Marcus C; Taghipour M; Subramaniam RM
    PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET and PET/CT imaging in thyroid and adrenal diseases: an update.
    Treglia G; Giovanella L; Rufini V
    Hormones (Athens); 2013; 12(3):327-33. PubMed ID: 24121375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET/CT imaging of thyroid cancer.
    Mosci C; Iagaru A
    Clin Nucl Med; 2011 Dec; 36(12):e180-5. PubMed ID: 22064103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary Thyroid Carcinoma: Imaging.
    Delorme S; Raue F
    Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive anaplastic thyroid carcinoma: report of a case and literature review.
    Dibelius G; Mehra S; Clain JB; Urken ML; Wenig BM
    Thyroid; 2014 Aug; 24(8):1319-24. PubMed ID: 24865498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
    Treglia G; Castaldi P; Villani MF; Perotti G; Filice A; Ambrosini V; Cremonini N; Versari A; Fanti S; Giordano A; Rufini V
    Recent Results Cancer Res; 2013; 194():385-93. PubMed ID: 22918771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
    Slavikova K; Montravers F; Treglia G; Kunikowska J; Kaliska L; Vereb M; Talbot JN; Balogova S
    Curr Radiopharm; 2013 Jun; 6(2):96-105. PubMed ID: 23745775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of PETCT in thyroid malignancies: an update.
    Palaniswamy SS; Subramanyam P
    Ann Nucl Med; 2013 Oct; 27(8):681-93. PubMed ID: 23801405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice Types.
    Twining CL; Lupo MA; Tuttle RM
    Endocr Pract; 2018 Sep; 24(9):833-840. PubMed ID: 30308136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
    Lauridsen JK; Rohde M; Thomassen A
    PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in predicting thyroid malignancy.
    Stang MT; Carty SE
    Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
    Salvatori M; Biondi B; Rufini V
    Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.